|
Q9982 |
 |
Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
| short | Flutemetamol f18 diagnostic |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 1.0 | 3 Date of Service Edit: Clinical | Nature of Service/Procedure | | OPH | 1.0 | 3 Date of Service Edit: Clinical | Nature of Service/Procedure |
|
|
|
|
Q9983 |
|
Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
| short | Florbetaben f18 diagnostic |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 1.0 | 3 Date of Service Edit: Clinical | Nature of Service/Procedure | | OPH | 1.0 | 3 Date of Service Edit: Clinical | Nature of Service/Procedure |
|
|
|
|
Q9984 |
|
Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg
|
|
|
Q9985 |
|
Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
| short | Inj hydroxyprogst capoat nos |
|
|
|
Q9986 |
|
Injection, hydroxyprogesterone caproate, (makena), 10 mg
|
|
|
Q9987 |
|
Pathogen(s) test for platelets
| short | Pathogen test for platelets |
|
|
|
Q9988 |
|
Platelets, pheresis, pathogen-reduced, each unit
| short | Platelets, pathogen reduced |
|
|
|
Q9989 |
|
Ustekinumab, for intravenous injection, 1 mg
| short | Ustekinumab, iv inject,1 mg |
|
|
|
Q9991 |
|
Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg
| short | Buprenorph xr 100 mg or less |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 1.0 | 3 Date of Service Edit: Clinical | Code Descriptor / CPT Instruction | | OPH | 1.0 | 3 Date of Service Edit: Clinical | Code Descriptor / CPT Instruction |
|
|
|
|
Q9992 |
|
Injection, buprenorphine extended-release (sublocade), greater than 100 mg
| short | Buprenorphine xr over 100 mg |
| RVU | | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
|---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
| MUE | | Location | Value | Ajudication Indicator | Rationale |
|---|
| PRA | 1.0 | 3 Date of Service Edit: Clinical | Code Descriptor / CPT Instruction | | OPH | 1.0 | 3 Date of Service Edit: Clinical | Code Descriptor / CPT Instruction |
|
|
|